Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-25
DOI
10.1038/s41401-020-0425-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- A Self‐Adjuvanting Vaccine Platform: Optimization of Site‐Specific Sortase A Mediated Conjugation of Toll‐Like Receptor 2 Ligands onto the Carboxyl or Amino terminus of Recombinant Protein Antigens
- (2020) Zhenghui Xu et al. ChemPlusChem
- Synthetic Immunogenic Cell Death Mediated by Intracellular Delivery of STING Agonist Nanoshells Enhances Anticancer Chemo-immunotherapy
- (2020) Saborni Chattopadhyay et al. NANO LETTERS
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
- (2019) Karim Vermaelen Frontiers in Immunology
- Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist
- (2019) Xiaohui Zhang et al. ACS Infectious Diseases
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 Agonists
- (2019) Jana De Vrieze et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bioactive modulators targeting STING adaptor in cGAS-STING pathway
- (2019) Xi Feng et al. DRUG DISCOVERY TODAY
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
- (2018) Markella Konstantinidou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
- (2018) Bayard R. Huck et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
- (2018) Lutz Nuhn et al. BIOMATERIALS
- Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant
- (2018) Zhifang Zhou et al. CHINESE CHEMICAL LETTERS
- The Latest Cancer Agents and Their Complications
- (2018) Sarah B. Dubbs EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
- Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir
- (2018) Miguel M. Leiva-Juarez et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
- (2018) Rui Kuai et al. JOURNAL OF CONTROLLED RELEASE
- The global landscape of cancer cell therapy
- (2018) Jun Tang et al. NATURE REVIEWS DRUG DISCOVERY
- Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
- (2018) Tadashi Hosoya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Immunization with recombinant truncated Neisseria meningitidis -Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae
- (2018) María Victoria Humbert et al. VACCINE
- Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy
- (2018) Yiting Qiao et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
- (2018) Maopeng Tian et al. Frontiers in Immunology
- Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy
- (2018) Bong Geun Cha et al. ACS Central Science
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- Dendritic Cell-Targeted Nanovaccine Delivery System Prepared with an Immune-Active Polymer
- (2018) Mrigendra K. S. Rajput et al. ACS Applied Materials & Interfaces
- Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency
- (2018) Yue Han et al. BIOMATERIALS
- Recent advances in small molecule based cancer immunotherapy
- (2018) Binbin Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
- (2018) Adam J.R. Gadd et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
- (2018) Shabnam Shaabani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Combined encapsulation of a tumor antigen and immune cells using a self-assembling immunostimulatory DNA hydrogel to enhance antigen-specific tumor immunity
- (2018) Yuka Umeki et al. JOURNAL OF CONTROLLED RELEASE
- Site-directed polymer-drug complexes for inflammatory bowel diseases (IBD): Formulation development, characterization, and pharmacological evaluation
- (2018) Siddharth S. Kesharwani et al. JOURNAL OF CONTROLLED RELEASE
- Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
- (2018) Malvina Pizzuto et al. JOURNAL OF CONTROLLED RELEASE
- TLR4-based immunotherapeutics in cancer: a review of the achievements and shortcomings
- (2018) Maryam A. Shetab Boushehri et al. MOLECULAR PHARMACEUTICS
- Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
- (2018) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Toll-Like Receptors for Cancer Therapy
- (2018) Marc J. Braunstein et al. Targeted Oncology
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses
- (2018) Lutz Nuhn et al. ADVANCED MATERIALS
- Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation
- (2018) Inès Mottas et al. BIOMATERIALS
- A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice
- (2018) Anshika Tandon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists
- (2018) Matthew D. Morin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles–TLR7/8 Agonist Conjugates
- (2018) Simon Van Herck et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Polymer–drug conjugate therapeutics: advances, insights and prospects
- (2018) Iriny Ekladious et al. NATURE REVIEWS DRUG DISCOVERY
- Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
- (2018) Marion Dajon et al. OncoImmunology
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
- (2018) Gijs G. Zom et al. Journal for ImmunoTherapy of Cancer
- Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
- (2017) Marion Dajon et al. IMMUNOBIOLOGY
- Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotide
- (2017) Oliver K. Appelbe et al. JOURNAL OF CONTROLLED RELEASE
- Developments and future clinical outlook of taxane nanomedicines
- (2017) Benoit Louage et al. JOURNAL OF CONTROLLED RELEASE
- Structure–Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
- (2017) Michael Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities
- (2017) Lei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens
- (2017) Tamiru N. Alkie et al. PLoS One
- Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity
- (2017) Michael Chan et al. ACS Combinatorial Science
- The role of toll-like receptor 4 in tumor microenvironment
- (2017) Jing Li et al. Oncotarget
- PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy
- (2016) Ju Yeon Choi et al. Acta Biomaterialia
- Self-Assembly of the Toll-Like Receptor Agonist Macrophage-Activating Lipopeptide MALP-2 and of Its Constituent Peptide
- (2016) Valeria Castelletto et al. BIOMACROMOLECULES
- Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy
- (2016) Alyssa L. Siefert et al. BIOMATERIALS
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
- (2016) Guanying Chen et al. CHEMICAL REVIEWS
- Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators
- (2016) Hilmar Weinmann ChemMedChem
- Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
- (2016) Héloïse Ragelle et al. Expert Opinion on Drug Delivery
- Dual-pH responsive micelle platform for co-delivery of axitinib and doxorubicin
- (2016) Xiuli Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Discovery and Structure–Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists
- (2016) Matthew D. Morin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation
- (2016) Jason D. Marshall et al. PLoS One
- TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS
- (2016) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation
- (2016) Lutz Nuhn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Toll-like receptor ligands on RAW 264.7 macrophage morphology and zymosan phagocytosis
- (2016) Lynette B. Sigola et al. TISSUE & CELL
- A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 ResponsesIn Vitro
- (2016) Stefan Schülke et al. Journal of Immunology Research
- A Cationic Micelle Complex Improves CD8+ T Cell Responses in Vaccination Against Unmodified Protein Antigen
- (2016) Carrie E. Brubaker et al. ACS Biomaterials-Science & Engineering
- Does Nanomedicine Have a Delivery Problem?
- (2016) Michael Torrice ACS Central Science
- A Cationic Micelle Complex Improves CD8+ T Cell Responses in Vaccination Against Unmodified Protein Antigen
- (2016) Carrie E. Brubaker et al. ACS Biomaterials Science & Engineering
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma
- (2015) Yuanyuan Guo et al. ACS Nano
- Transiently responsive protein–polymer conjugates via a ‘grafting-from’ RAFT approach for intracellular co-delivery of proteins and immune-modulators
- (2015) N. Vanparijs et al. CHEMICAL COMMUNICATIONS
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Toll-Like Receptor 7 Inactive Ligands Enhanced Cytokine Induction by Conjugation to Weak Antigens
- (2015) Dong Gao et al. ChemMedChem
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses
- (2015) Martine A. Boks et al. JOURNAL OF CONTROLLED RELEASE
- Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens
- (2015) Yuchen Fan et al. JOURNAL OF CONTROLLED RELEASE
- Nontoxic antimicrobials that evade drug resistance
- (2015) Stephen A Davis et al. Nature Chemical Biology
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth
- (2015) Ju Yeon Choi et al. Journal of Materials Chemistry B
- Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
- (2015) Janine K. Tom et al. ACS Central Science
- Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
- (2015) K. Cheng et al. Science Advances
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Smart chemistry in polymeric nanomedicine
- (2014) Rong Tong et al. CHEMICAL SOCIETY REVIEWS
- Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity
- (2014) Bao-Zhong Wang et al. JOURNAL OF CONTROLLED RELEASE
- Euodenine A: A Small-Molecule Agonist of Human TLR4
- (2014) Juliette E. Neve et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines
- (2014) Sebastian Hartmann et al. Advanced Healthcare Materials
- Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
- (2014) G. G. Zom et al. Cancer Immunology Research
- Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
- (2013) Annina M. Hafner et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
- (2013) Susan N. Thomas et al. BIOMATERIALS
- Immunomodulatory effects of carbon nanotubes functionalized with a Toll-like receptor 7 agonist on human dendritic cells
- (2013) Miodrag Čolić et al. CARBON
- TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production
- (2013) Anje Cauwels et al. CARDIOVASCULAR RESEARCH
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
- (2013) Michael Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Recent trends in the design of anticancer polymer prodrug nanocarriers
- (2013) Vianney Delplace et al. Polymer Chemistry
- TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses
- (2013) Christopher B. Fox et al. VACCINE
- Endocytosis at the nanoscale
- (2012) Irene Canton et al. CHEMICAL SOCIETY REVIEWS
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Polyelectrolyte Capsules as Carriers for Growth Factor Inhibitor Delivery to Hepatocellular Carcinoma
- (2012) Francesca Baldassarre et al. MACROMOLECULAR BIOSCIENCE
- Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
- (2012) James J. Moon et al. PLoS One
- Modulation of γδ T cell responses by TLR ligands
- (2011) Daniela Wesch et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Regulation of T cell activation by TLR ligands
- (2011) Hans-Heinrich Oberg et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses
- (2011) Mohamed Labib Salem IMMUNOLOGY LETTERS
- Soluble Proteins Induce Strong CD8+ T Cell and Antibody Responses through Electrostatic Association with Simple Cationic or Anionic Lipopeptides That Target TLR2
- (2011) B. Y. Chua et al. JOURNAL OF IMMUNOLOGY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Systemic Stimulation of TLR2 Impairs Neonatal Mouse Brain Development
- (2011) Xiaonan Du et al. PLoS One
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes
- (2010) Erdem Erikçi et al. BIOMATERIALS
- Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening
- (2010) Yue Guan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antigen-Containing Liposomes Engrafted with Flagellin-Related Peptides Are Effective Vaccines That Can Induce Potent Antitumor Immunity and Immunotherapeutic Effect
- (2010) A. Faham et al. JOURNAL OF IMMUNOLOGY
- Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
- (2010) Xiaoxia Z. West et al. NATURE
- Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
- (2009) Michael Chan et al. BIOCONJUGATE CHEMISTRY
- Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity
- (2009) Juan R. Cubillos-Ruiz et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells
- (2008) Selina Khan et al. MOLECULAR IMMUNOLOGY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Amphotericin B Formulations and Drug Targeting
- (2007) J.J. Torrado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now